您的位置: 首页 > 农业专利 > 详情页

-2,3-Dihydro-benzo [1,4] oxazine derivatives and related compounds such as phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of rheumatoid arthritis
专利权人:
Novartis AG
发明人:
CARAVATTI, Giorgio,CHAMOIN, Sylvie,FURET, Pascal,HÖGENAUER, Klemens,HURTH, Konstanze,KALIS, Christoph,KAMMERTOENS, Karen,LEWIS, Ian,MOEBITZ, Henrik,SMITH, Alexander Baxter,SOLDERMANN, Nicolas,WOLF, Ro
申请号:
DK12823036
公开号:
DK2794600T3
申请日:
2012.12.20
申请国别(地区):
DK
年份:
2018
代理人:
摘要:
The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充